Possible activation of murine T lymphocyte through CD98 is independent of interleukin 2/interleukin 2 receptor system

Biomed Res. 2006 Apr;27(2):61-7. doi: 10.2220/biomedres.27.61.

Abstract

CD98 is a widely expressed cell surface heterodimeric protein of 125 kDa. Its expression is upregulated during lymphocyte activation induced by mitogen, superantigen, conventional antigen, and a combination of phorbol myristate acetate (PMA) and ionomycin. However, the role of CD98 in the immune system is not so well understood. The role of CD98 in murine T lymphocyte proliferation was investigated, especially in correlation with the interleukin 2 (IL-2)/interleukin 2 receptor (IL-2R) system. Monoclonal antibody (mAb) directed against murine CD98 heavy chain (mCD98HC) suppressed the proliferation of lymphocytes stimulated with concanavalin A (Con A). Anti-mCD98HC mAb did not suppress the expression of IL-2Ralpha. Anti-IL-2Ralpha mAb, which suppressed DNA synthesis, did not inhibit the expression of CD98HC. Murine IL-2 (recombinant), which induced considerable DNA synthesis by lymphocytes stimulated with a sub-optimal dose of Con A, did not induce CD98HC expression in lymphocytes. In addition, anti-mCD98HC mAb did not inhibit the production of IL-2 by lymphocyte stimulated with Con A. Taken together with these findings, it was speculated that the CD98 system is independent of the IL-2/IL-2R system in murine T lymphocyte activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / metabolism
  • Concanavalin A / pharmacology
  • Fusion Regulatory Protein 1, Heavy Chain / immunology*
  • Interleukin-2 / immunology*
  • Lymphocyte Activation*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Receptors, Interleukin-2 / immunology*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*

Substances

  • Antibodies, Monoclonal
  • Fusion Regulatory Protein 1, Heavy Chain
  • Interleukin-2
  • Receptors, Interleukin-2
  • Concanavalin A